Ronald A. Hinder
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ronald A. Hinder has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
P J Klingler
Department of Surgery, Mayo Clinic Jacksonville 32224, USA
7 shared publicationsAlexander Klaus
Mayo Clinic Jacksonville
4 shared publicationsSami R. Achem
Mayo Clinic Jacksonville
4 shared publicationsHugo Bonatti
Department of Surgery, Mayo Clinic Jacksonville, Jacksonville, FL 32224, USA
3 shared publicationsC J Filipi
2 shared publicationsG Perdikis
2 shared publications
Latest Publications
- Open Access
- 1 February 2008
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 12 (2) , 373-381
Impact of Changing Epidemiology of Gastroesophageal Reflux Disease on its Diagnosis and Treatment
- 1 February 2008
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 12 (2) , 373-381
Open AccessImpact of Changing Epidemiology of Gastroesophageal Reflux Disease on its Diagnosis and Treatment
- 1 July 2007
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 11 (7) , 923-928
Technical Considerations in Laparoscopic Fundoplication
- 1 July 2007
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 11 (7) , 923-928
Technical Considerations in Laparoscopic Fundoplication
- 5 May 2007
- Published by Springer Nature in Surgical Endoscopy
- Vol. 21 (11) , 1975-1977
Late Gastric Perforations After Laparoscopic Fundoplication
Background Late complications are rarely encountered after laparoscopic Nissen fundoplication. These complications include acute gastric herniation through the esophageal hiatus, port-site herniation, recurrent reflux, and anatomic failure of the fundoplication. Only three cases of late gastric perforation after laparoscopic Nissen fundoplication have been reported, all associated with intrathoracic wrap herniation. Methods We retrospectively reviewed all cases of gastric perforation after laparoscopic antireflux procedures performed between July 1991 and March 2002 by a single surgeon. Results In this series of 1,600 laparoscopic antireflux procedures, we found six delayed gastric fundal perforations occurring in three patients at 1, 41, 48, 51, 68, and 72 months after surgery. All the perforations were on the anterior wall of the fundus of the stomach and were distant from the stitches of the fundoplication. None of the perforations was associated with severe peritoneal contamination. Conclusions This series of late gastric fundal perforations in 0.2% of our patients after laparoscopic fundoplication may have been caused by medications, gastric stasis, ischemia, or a foreign body such as a stitch or Teflon pledget.
- 5 May 2007
- Published by Springer Nature in Surgical Endoscopy
- Vol. 21 (11) , 1975-1977
Late Gastric Perforations After Laparoscopic Fundoplication
Background Late complications are rarely encountered after laparoscopic Nissen fundoplication. These complications include acute gastric herniation through the esophageal hiatus, port-site herniation, recurrent reflux, and anatomic failure of the fundoplication. Only three cases of late gastric perforation after laparoscopic Nissen fundoplication have been reported, all associated with intrathoracic wrap herniation. Methods We retrospectively reviewed all cases of gastric perforation after laparoscopic antireflux procedures performed between July 1991 and March 2002 by a single surgeon. Results In this series of 1,600 laparoscopic antireflux procedures, we found six delayed gastric fundal perforations occurring in three patients at 1, 41, 48, 51, 68, and 72 months after surgery. All the perforations were on the anterior wall of the fundus of the stomach and were distant from the stitches of the fundoplication. None of the perforations was associated with severe peritoneal contamination. Conclusions This series of late gastric fundal perforations in 0.2% of our patients after laparoscopic fundoplication may have been caused by medications, gastric stasis, ischemia, or a foreign body such as a stitch or Teflon pledget.
- 1 April 2007
- Published by Elsevier in Digestive and Liver Disease
- Vol. 39 (4) , 319-320
A question of gas
- 1 April 2007
- Published by Elsevier in Digestive and Liver Disease
- Vol. 39 (4) , 319-320
A question of gas
- 7 December 2006
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 52 (1) , 267-272
Use of Acid Suppressive Medications After Laparoscopic Antireflux Surgery: Prevalence and Clinical Indications
Laparoscopic antireflux surgery (LARS) provides effective control of gastroesophageal reflux (GER) in more than 90% of patients. Despite this high success rate, some patients continue to consume acid suppressive medications after surgical intervention. In this study we evaluate the prevalence, clinical indications, and cause of use of acid reducing drugs in patients after LARS. Consecutive patients undergoing LARS for GERD were surveyed 2–3 years after surgery regarding use of acid suppressive medications, surgical outcome, and GERD specific symptoms. During the study period, 119 patients underwent LARS at our center. Ninety-eight (82%) were available for interview. Two patients died of unrelated causes and two declined to be interviewed. The remaining 94 individuals are the subject of this report. Ninety-four percent were satisfied with the outcome of surgery. Despite this high satisfaction rate, 37 of 94 (39%) were on antireflux medication (ARM; 62% proton pump inhibitors, 22% H2-receptor antagonists, and 16% others), with 70% using continuous medication. Of these patients, 54% took ARM after surgery for GERD-related symptoms, 95% of these patients responded to medical therapy, and yet again, 85% remained satisfied with the surgical outcome. Forty-six percent of patients on ARM after surgery had no GERD symptoms and took ARM for nonappropriate indications such as bloating. Only 47% of these responded to ARM; 82% of this group was satisfied with the surgical outcome. In conclusion, the use of ARM after LARS is a common occurrence despite a high satisfaction rate with this operation. Nearly half of patients consuming ARS after LARS are taking these medications for symptoms not necessarily related to GER. These findings underscore the importance of patient education in the use of these agents.
- 7 December 2006
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 52 (1) , 267-272
Use of Acid Suppressive Medications After Laparoscopic Antireflux Surgery: Prevalence and Clinical Indications
Laparoscopic antireflux surgery (LARS) provides effective control of gastroesophageal reflux (GER) in more than 90% of patients. Despite this high success rate, some patients continue to consume acid suppressive medications after surgical intervention. In this study we evaluate the prevalence, clinical indications, and cause of use of acid reducing drugs in patients after LARS. Consecutive patients undergoing LARS for GERD were surveyed 2–3 years after surgery regarding use of acid suppressive medications, surgical outcome, and GERD specific symptoms. During the study period, 119 patients underwent LARS at our center. Ninety-eight (82%) were available for interview. Two patients died of unrelated causes and two declined to be interviewed. The remaining 94 individuals are the subject of this report. Ninety-four percent were satisfied with the outcome of surgery. Despite this high satisfaction rate, 37 of 94 (39%) were on antireflux medication (ARM; 62% proton pump inhibitors, 22% H2-receptor antagonists, and 16% others), with 70% using continuous medication. Of these patients, 54% took ARM after surgery for GERD-related symptoms, 95% of these patients responded to medical therapy, and yet again, 85% remained satisfied with the surgical outcome. Forty-six percent of patients on ARM after surgery had no GERD symptoms and took ARM for nonappropriate indications such as bloating. Only 47% of these responded to ARM; 82% of this group was satisfied with the surgical outcome. In conclusion, the use of ARM after LARS is a common occurrence despite a high satisfaction rate with this operation. Nearly half of patients consuming ARS after LARS are taking these medications for symptoms not necessarily related to GER. These findings underscore the importance of patient education in the use of these agents.
- 1 August 2006
- Published by Springer Nature in European Surgery
- Vol. 38 (4) , 244-249
The laparoscopic fundoplications: Nissen and partial posterior (Toupet) fundoplication
- 1 August 2006
- Published by Springer Nature in European Surgery
- Vol. 38 (4) , 244-249
The laparoscopic fundoplications: Nissen and partial posterior (Toupet) fundoplication
- 1 August 2006
- Published by Springer Nature in European Surgery
- Vol. 38 (4) , 250-254
Derzeitiger Stand der Refundoplikation
- 1 August 2006
- Published by Springer Nature in European Surgery
- Vol. 38 (4) , 250-254
Derzeitiger Stand der Refundoplikation
- 1 December 2003
- Published by Elsevier in The American Journal of Surgery
- Vol. 186 (6) , 747-751
Small bowel transit and gastric emptying after biliodigestive anastomosis using the uncut jejunal loop
- 1 December 2003
- Published by Elsevier in The American Journal of Surgery
- Vol. 186 (6) , 747-751
Small bowel transit and gastric emptying after biliodigestive anastomosis using the uncut jejunal loop
- 1 November 2003
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 7 (7) , 906-911
Management of epiphrenic diverticula
- 1 November 2003
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 7 (7) , 906-911
Management of epiphrenic diverticula
- 1 December 2001
- Vol. 8 (4) , 234-9
Indications for antireflux surgery in Barrett's.
One of the most common complications of gastroesophageal reflux disease is Barrett's esophagus. Medical therapy for this condition is not very effective and does not seem to be able to control the occurence and progression of the disease. In contrast, there is some evidence that effective antireflux surgery does have a slowing effect on the occurence and the progression of Barrett's esophagus. There is also some evidence that the progression of Barrett's to high-grade dysplasia and carcinoma is less after antireflux surgery than during medical therapy. Antireflux surgery should be considered in patients with Barrett's who have a large hiatal hernia, dysplasia, a weak lower esophageal sphincter pressure, failed medical therapy, noncompliance to medications, and young age.
- 1 December 2001
- Vol. 8 (4) , 234-9
Indications for antireflux surgery in Barrett's.
One of the most common complications of gastroesophageal reflux disease is Barrett's esophagus. Medical therapy for this condition is not very effective and does not seem to be able to control the occurence and progression of the disease. In contrast, there is some evidence that effective antireflux surgery does have a slowing effect on the occurence and the progression of Barrett's esophagus. There is also some evidence that the progression of Barrett's to high-grade dysplasia and carcinoma is less after antireflux surgery than during medical therapy. Antireflux surgery should be considered in patients with Barrett's who have a large hiatal hernia, dysplasia, a weak lower esophageal sphincter pressure, failed medical therapy, noncompliance to medications, and young age.